Publication | Closed Access
The ?2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats
34
Citations
49
References
2003
Year
Medicine2-Adrenoceptor AntagonistPharmacological AgentNeuropharmacologyPharmacotherapyNeurologyNeuroscienceDopaminergic DrugsAnti-parkinsonian EffectsDopaminePharmacologyDrug DiscoveryNeuropeptides
| Year | Citations | |
|---|---|---|
Page 1
Page 1